Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center



Status:Completed
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - 89
Updated:2/17/2019
Start Date:March 23, 2017
End Date:March 30, 2018

Use our guide to learn which trials are right for you!

The purpose of this study is to determine whether glaucoma drop aids will be cost-effective
in delivery of ophthalmic medications by improving medication compliance, visual function,
and even decreasing medication waste in the patient population at Boston Medical Center
(BMC).

Patients being treated for their glaucoma at BMC's Yawkey Eye Clinic will be selected
according to the inclusion and exclusion criteria. The three drop aids used in this study
will be the Fabrication Autodrop Eye Drop Guide, Owen Mumford OP 6100 Autosqueeze, and the
Simply Touch Eye Drop Applicator. Patients will be randomly placed on one of these drops aids
for a total of 3 study groups or the no drop aid control, for a total of 4 groups. Prior to
use of the drop aid, patients will be instructed on how to use the drop aid by a resident
physician and a pre- intervention intraocular pressure check will be performed by the
resident physician using an applicator. Intraocular pressure is the only adjustable risk
factor for glaucoma; thus, glaucoma treatments slow progression of glaucoma by reducing
intraocular pressure. In addition, patients will be requested to deliver their drops with the
drop aid with every use. Furthermore, each patient will record the number of days taken to
complete the glaucoma medication bottle while using the drop aid. At the 3 and 6 week marks,
the patient will fill out a satisfaction survey. Patients will need to return to the clinic
at the 6 week mark and can fill out the satisfaction survey at the clinic in addition to
checking the intraocular pressure post-intervention. Thus, the number of subject contact will
be two, pre and post-intervention, the duration of participation for each subject will be 6
weeks, and the patient will also be required to fill out two satisfaction surveys. The
effectiveness of the drop aids will be compared to the two controls and measured with any
changes in intraocular pressure readings, length of time to medication completion, and
patient satisfaction according to the surveys.

Inclusion Criteria:

- age 18 years or greater

- Currently on the same topical medication for treatment of glaucoma for a minimum of
two months

- Patient of Boston University eye Associates

- Agrees to use the drop aid with each delivery, return to the clinic after 6 weeks of
using the drop aid, document completion of medication drops and fill out survey at the
end of the 6 weeks

Exclusion Criteria:

- Less than age 18 years

- Changes glaucoma medication within the past two month or recent glaucoma surgery

- Older than 89 years of age

- Not a patient of the Boston University eye associate
We found this trial at
1
site
Boston, Massachusetts 02118
Principal Investigator: Manishi Desai, MD
Phone: 617-414-8848
?
mi
from
Boston, MA
Click here to add this to my saved trials